These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19063682)

  • 1. PTH and PTH antagonist induce different conformational changes in the PTHR1 receptor.
    Thomas BE; Sharma S; Mierke DF; Rosenblatt M
    J Bone Miner Res; 2009 May; 24(5):925-34. PubMed ID: 19063682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational changes in the parathyroid hormone receptor associated with activation by agonist.
    Thomas BE; Woznica I; Mierke DF; Wittelsberger A; Rosenblatt M
    Mol Endocrinol; 2008 May; 22(5):1154-62. PubMed ID: 18258686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping peptide hormone-receptor interactions using a disulfide-trapping approach.
    Monaghan P; Thomas BE; Woznica I; Wittelsberger A; Mierke DF; Rosenblatt M
    Biochemistry; 2008 Jun; 47(22):5889-95. PubMed ID: 18459800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of the small molecule ligands SW106 and AH-3960 on the type-1 parathyroid hormone receptor.
    Carter PH; Dean T; Bhayana B; Khatri A; Rajur R; Gardella TJ
    Mol Endocrinol; 2015 Feb; 29(2):307-21. PubMed ID: 25584411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine at position 217 in the intracellular loop 1 plays a critical role in human PTH receptor type 1 membrane translocation and function.
    Thomas BE; Wittelsberger A; Woznica I; Hsieh MY; Monaghan P; Lee BK; Rosenblatt M
    J Bone Miner Res; 2007 Apr; 22(4):609-16. PubMed ID: 17227205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Backbone Modification of a Parathyroid Hormone Receptor-1 Antagonist/Inverse Agonist.
    Cheloha RW; Watanabe T; Dean T; Gellman SH; Gardella TJ
    ACS Chem Biol; 2016 Oct; 11(10):2752-2762. PubMed ID: 27533344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an agonist-induced conformational change occurring adjacent to the ligand-binding pocket of the M(3) muscarinic acetylcholine receptor.
    Han SJ; Hamdan FF; Kim SK; Jacobson KA; Bloodworth LM; Li B; Wess J
    J Biol Chem; 2005 Oct; 280(41):34849-58. PubMed ID: 16093246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling.
    Hattersley G; Dean T; Corbin BA; Bahar H; Gardella TJ
    Endocrinology; 2016 Jan; 157(1):141-9. PubMed ID: 26562265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-specific changes in M3 muscarinic acetylcholine receptor structure detected by a disulfide scanning strategy.
    Li JH; Hamdan FF; Kim SK; Jacobson KA; Zhang X; Han SJ; Wess J
    Biochemistry; 2008 Mar; 47(9):2776-88. PubMed ID: 18247581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the extracellular regions of the parathyroid hormone (PTH)/PTH-related peptide receptor in hormone binding.
    Lee C; Gardella TJ; Abou-Samra AB; Nussbaum SR; Segre GV; Potts JT; Kronenberg HM; Jüppner H
    Endocrinology; 1994 Oct; 135(4):1488-95. PubMed ID: 7523099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mid-region of parathyroid hormone (1-34) serves as a functional docking domain in receptor activation.
    Wittelsberger A; Corich M; Thomas BE; Lee BK; Barazza A; Czodrowski P; Mierke DF; Chorev M; Rosenblatt M
    Biochemistry; 2006 Feb; 45(7):2027-34. PubMed ID: 16475791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probe.
    Carter PH; Liu RQ; Foster WR; Tamasi JA; Tebben AJ; Favata M; Staal A; Cvijic ME; French MH; Dell V; Apanovitch D; Lei M; Zhao Q; Cunningham M; Decicco CP; Trzaskos JM; Feyen JH
    Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6846-51. PubMed ID: 17428923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative interaction of arginine-19 and the N-terminal signaling domain in the affinity and potency of parathyroid hormone.
    Tsomaia N; Shimizu M; Shimizu N; Gardella TJ; Mierke DF
    Biochemistry; 2004 Mar; 43(12):3459-70. PubMed ID: 15035617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-Dependent Effects of Methionine-8 Oxidation in Parathyroid Hormone Peptide Analogues.
    Daley EJ; Khatri A; Dean T; Vilardaga JP; Zaidi SA; Katritch V; Gardella TJ
    Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33242090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoaffinity cross-linking identifies differences in the interactions of an agonist and an antagonist with the parathyroid hormone/parathyroid hormone-related protein receptor.
    Behar V; Bisello A; Bitan G; Rosenblatt M; Chorev M
    J Biol Chem; 2000 Jan; 275(1):9-17. PubMed ID: 10617579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformations.
    Dean T; Linglart A; Mahon MJ; Bastepe M; Jüppner H; Potts JT; Gardella TJ
    Mol Endocrinol; 2006 Apr; 20(4):931-43. PubMed ID: 16339275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimization of parathyroid hormone. Novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor.
    Shimizu M; Potts JT; Gardella TJ
    J Biol Chem; 2000 Jul; 275(29):21836-43. PubMed ID: 10777513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of parathyroid hormone (PTH)/secretin receptor chimeras differentiates the role of functional domains in the pth/ pth-related peptide (PTHrP) receptor on hormone binding and receptor activation.
    Vilardaga JP; Lin I; Nissenson RA
    Mol Endocrinol; 2001 Jul; 15(7):1186-99. PubMed ID: 11435617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino-terminal parathyroid hormone fragment analogs containing alpha,alpha-di-alkyl amino acids at positions 1 and 3.
    Shimizu N; Dean T; Khatri A; Gardella TJ
    J Bone Miner Res; 2004 Dec; 19(12):2078-86. PubMed ID: 15537452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors.
    Hoare SR; Usdin TB
    Curr Pharm Des; 2001 May; 7(8):689-713. PubMed ID: 11375776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.